Highly sensitive biomarker panels

作者: Philippe J. Goix , Robert Puskas , Douglas Held , Sara Le , John Todd

DOI:

关键词:

摘要: Cardiovascular disease, e.g., congestive heart failure, is often first diagnosed after the onset of clinical symptoms, eliminating potential for early intervention. The invention provides a multi-marker immunoassay, including cardiac pathology and vascular inflammation biomarkers, yielding more sensitive assay detection CHF in plasma. A panel consisting (cTnI, BNP) (IL-6, TNFα, IL-17a) biomarkers provided sensitivity 94% association with CHF.

参考文章(355)
İbrahim Özdoğru, Ramazan Topsakal, Namık Kemal Eryol, Abdurrahman Oğuzhan, Adnan Abacı, Emrullah Başar, Servet Çetiner, Yüksel Çiçek, Should troponin-T be assessed during exercise stress testing in patients with stable angina pectoris? Anatolian Journal of Cardiology. ,vol. 2, pp. 132- 137 ,(2002)
William E. Cayley, Diagnosing the Cause of Chest Pain American Family Physician. ,vol. 72, pp. 2012- 2021 ,(2005)
Y Collan, M Eskelinen, S Tikanoja, A new tumor marker MCA in breast cancer diagnosis. Anticancer Research. ,vol. 8, pp. 665- 668 ,(1988)
Amit Novik, Zurit Levine, Yossi Cohen, Gad S. Cojocaru, Sarah Pollock, Michal Ayalon-Soffer, Alexander Diber, Brain natriuretic peptide spliced variant ,(2005)
Eberhard Gladrow, Thomas Demant, Walter Hubl, Evaluation of the ARCHITECT STAT troponin-I assay. Clinical Laboratory. ,vol. 51, pp. 251- ,(2005)
John T. Mcdevitt, Pierre N. Floriano, Craig S. Miller, Jeff Ebersole, Nicolaos Christodoulides, Cardibioindex/cardibioscore and utility of salivary proteome in cardiovascular diagnostics ,(2008)